News

Dr Mike Youle from the Royal Free Hospital, London said: “We are seeing a consistent Fuzeon effect with these new drugs and I believe these data must change

Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have demonstrated that leakage appears to occur between the blood vessels and the brain, as a result of which

Researchers at the McGill University Health Centre (MUHC) in Canada have investigated a debilitating hereditary form of migraine which is accompanied by visual impairments known as auras. The

454 Life Sciences and Roche entered into the five-year, world-wide agreement in May, 2005. Under the terms of the agreement, 454 Life Sciences will receive up to $62

Under the agreement Genentech will use the Immunogen compounds in combination with its own therapeutic antibodies, on particular undisclosed targets. Shares in ImmunoGen climbed almost 10% in the

Entry inhibitors like aplaviroc represent a new mechanism of action in this class of drugs, and potentially a new way of treating patients with HIV. They work by

C difficile infection, which is characterized by diarrhea and colitis, represents one of the most common hospital acquired infections around the world. A new virulent strain of C

Tapestry expects savings from this downsizing, and other cost saving measures, to total approximately $7.4 million through the end of 2006; however about 14 people, or 30% of

Namenda was approved by the FDA for the treatment of moderate to severe Alzheimer’s disease in October 2003. However, the US regulator has now raised questions regarding the